about
Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assayType 1 diabetes: translating mechanistic observations into effective clinical outcomesImmune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD MiceType 1 diabetes mellitus.Manganese-enhanced magnetic resonance imaging detects declining pancreatic β-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes.Spatiotemporal Dynamics of Insulitis in Human Type 1 DiabetesMig6 haploinsufficiency protects mice against streptozotocin-induced diabetesCharacteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionPhase transitions in pancreatic islet cellular networks and implications for type-1 diabetes.Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsβ-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up.Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death.Diabetes Associated Metabolomic Perturbations in NOD Mice.Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetesDetection of β cell death in diabetes using differentially methylated circulating DNA.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.Evidence for Residual and Partly Reparable Insulin Secretory Function and Maintained β-Cell Gene Expression in Islets From Patients With Type 1 DiabetesThinking bedside at the bench: the NOD mouse model of T1DM.Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 DiabetesChanges in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetesBiphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onsetIslet autoantigens: structure, function, localization, and regulation.Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 DiabetesElevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes.A genetic mouse model for progressive ablation and regeneration of insulin producing beta-cells.SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progressionTeplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trialThe pathogenesis and natural history of type 1 diabetes.Blood-based signatures in type 1 diabetes.TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferationInfluence of islet function on typing and prognosis of new-onset diabetes after intensive insulin therapyThe role of adipose-derived inflammatory cytokines in type 1 diabetesNew definition for the partial remission period in children and adolescents with type 1 diabetesImmunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futureHistopathology of type 1 diabetes: old paradigms and new insights.Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.Type 1 diabetes: etiology, immunology, and therapeutic strategies.
P2860
Q24600478-1B2F263D-5141-467F-8BEE-157AF890B30BQ28287737-92DC45E0-81A5-453B-9428-F914D975DECBQ28551036-B40CBE8B-726F-4190-B4D2-221246F6CEFCQ30235021-816AB8DE-8255-4ADC-96B7-DE08E0FE2B1CQ30415463-1B9FD4B8-4254-4A97-BDAA-A1CC1F2CDB83Q30833054-17BE72BA-7924-4F64-B249-391B01E86D9BQ34143192-66A2B58F-1CD0-4B35-86EE-39FE9126EEBDQ34181376-8B4ECDE8-EDD4-4D4D-82AC-A6E9E809E45FQ34234603-1A3C2D28-2DC6-4175-8733-4E0FFF72721EQ34260546-370418AC-8D27-461A-9E51-FA57E2C42622Q34497677-2E697209-4BC9-4AEE-9D68-FF8924CD7F29Q34615460-025D16A9-0A3F-4F94-809F-65737169F548Q35116303-B590D053-1DA0-4F1E-8965-D0EA105218E5Q35125149-9CDF3A7F-1B85-4D03-9B70-1CA8CD424ACCQ35145076-8311A5E8-F020-4A36-8095-C24E571917EDQ35153961-227AB574-4D2F-4B35-896F-612AB337ACEBQ35167112-03BB06CA-C9CF-40CA-9CAF-B03532AF300CQ35571341-D6EDB1F1-4C8B-40E5-8027-C1910D13FF74Q35674747-7E13CCA2-7135-41AD-868E-9C0982C0860BQ35769558-7129023B-6439-4FB1-8F31-D3FD9BC2D751Q35911875-2A137894-B702-43D4-8BD6-D15A4E843861Q35998318-374E03FB-9E7A-4AF8-8D9A-73F34A4636E5Q36001688-C60AC799-97D3-4B3C-A55C-4D735C612249Q36006024-AEB6C6BB-A4AE-4C08-B55B-6DBB6B691DEAQ36119378-D496645B-61E6-43FC-BCAA-BA290BB587B4Q36186271-8D5414BE-291C-4CD9-AF28-BB3C564AB06AQ36186286-87D716EB-CA38-4BBA-8314-B40C92388115Q36188547-0734786C-2693-4626-8859-4EEBD4E0CF29Q36325236-5EBE25D3-917D-458F-9A62-FCBA89628434Q36510973-2C4416F6-5BB3-429A-8C9D-77D084A810DBQ36526611-D5F6DDC7-F624-4219-AC15-501B23007E6DQ36552481-18B0789E-1015-4903-8E51-207E465F0BB6Q36720507-3464D686-91F2-48E6-B3CF-A91CB6E4AAFCQ37209420-8379B435-0D24-40F8-9757-172F62D7EDAFQ37238016-DE49D08D-B2FE-4035-A255-D9EC361455F1Q37269446-6FEDB70E-8E13-4496-A130-7BDF3F341056Q37364899-CEDA245C-6B39-41AC-BA4D-9D90ECBB8730Q37425106-E5BAB6E7-DBC5-46D1-AAE3-60EF890BEF15Q37567856-83409577-7810-45D4-AE7A-31B41FD42F18Q37830198-897CE3EA-1F3A-4404-9F15-0BEA57285CF3
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Beta-cell mass and type 1 diabetes: going, going, gone?
@en
type
label
Beta-cell mass and type 1 diabetes: going, going, gone?
@en
prefLabel
Beta-cell mass and type 1 diabetes: going, going, gone?
@en
P2093
P2860
P921
P356
P1433
P1476
Beta-cell mass and type 1 diabetes: going, going, gone?
@en
P2093
Eitan Akirav
Jake A Kushner
Kevan C Herold
P2860
P304
P356
10.2337/DB07-1817
P407
P5008
P577
2008-11-01T00:00:00Z